article

Thiopurine methyltransferase or thiopurine S-methyltransferase (TPMT) is an enzyme () that methylates thiopurine compounds. The methyl donor is S-adenosyl-L-methionine, which is converted to S-adenosyl-L-homocysteine.

Pharmacology


TPMT is best known for its role in the metabolism of the drugs 6-mercaptopurine, azathioprine and 6-thioguanine.

Diagnostic use


Measurement of TPMT activity is encouraged prior to commencing this medication, as patients with low activity (10% prevalence) or especially absent activity (prevalence 0.3%) are at a heightened risk of drug-induced bone marrow toxicity due to accumulation of the unmetabolised drug. Reuther et al found that 5% of all cases of thiopurine toxicity could be anticipated by routine measurement of TPMT activity.

References


  • Reuther LO, Vainer B, Sonne J, Larsen NE. Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity. Eur J Clin Pharmacol 2004;59:797-801. PMID 14634700.

External link


EC 2.1.1

 

This article is licensed under the GNU Free Documentation License. It uses material from the "Thiopurine methyltransferase".

Home Pageartsbusinesscomputersgameshealthhospitalshomekids & teensnewsphysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld